1
new Dietary Reference Intakes for vitamin D established by the Institute of Medicine (IOM). 1 An IOM committee on which we served, charged with determin ing the population needs for vitamin D in North America, re viewed the evidence linking vita min D with both skeletal and nonskeletal health outcomes. The committee concluded that vita min D plays an important role in bone health and that the evi dence provides a sound basis for determining the population's needs. For outcomes beyond bone health, however, including cancer, cardiovascular disease, diabetes, and autoimmune dis orders, the evidence was found to be inconsistent and inconclu sive as to causality.
Based on vitamin D's impor tance to bone health, the re commended dietary allowances (RDAs) are 600 IU per day for persons 1 to 70 years of age and 800 IU per day for persons over 70 -intakes corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng per millili ter (50 nmol per liter). Because of wide variation in skin synthe sis of vitamin D and the known risks of skin cancer, we derived the RDAs under the assumption that sun exposure would be min imal. The committee also con cluded that the prevalence of vi tamin D inadequacy in North ) . [1] [2] [3] Regarding breastcancer risk specifically, three observational cohort studies of plasma 25 hydroxyvitamin D levels had in consistent results: one small study found an inverse associa tion, one large study found no association, and one large study found no overall trend but an inverse association in one sub group. 1,2 An inverse association observed in crude analyses in one study disappeared after ad justment for bodymass index and physical activity. Only one randomized trial (the Women's Health Initiative [WHI] trial) was large enough to assess breast cancer as a separate, although secondary, outcome; overall, it showed no significant effect of the intervention on breastcan cer incidence (hazard ratio, 0.96; 95% confidence interval [CI], 0.86 to 1.07) or related mortality (hazard ratio, 0.99). After strati fying the study population ac cording to baseline vitamin D intake (diet plus supplements), the investigators found that women with the lowest baseline intakes had a reduced risk of breast cancer with the interven tion (hazard ratio, 0.79; 95% CI, 0.65 to 0.97), whereas women with the highest baseline intakes (≥600 IU per day) actually had a significantly increased risk (haz ard ratio, 1.34; 95% CI, 1.01 to 1.78; P for interaction = 0.003).
Observational studies of se rum vitamin D levels and colo rectal cancer generally support an inverse association. 1-3 According to a metaanalysis of prospective data from five studies, subjects with a serum 25hydroxyvitamin D level of 33 ng per milliliter or higher had about half the risk of colorectal cancer of those with levels of 12 ng per milliliter or lower. The European Prospective Investigation into Cancer and Nutrition study recently reported a similarly strong inverse asso ciation. A prospective study from the Japan Public Health Center 
